23rd Jan 2006 17:18
23 January 2006Shire plc (the "Company")The trustee of the Shire plc Employee Benefit Trust (the "Trust") notified theCompany on 20 January 2006 that, on that day, it exercised its discretion andreleased a total of 1,325 ordinary shares in the Company for nil consideration,being the release of shares to a beneficiary of the Trust on satisfaction of anaward under the Shire Pharmaceuticals 2003 Deferred Bonus Plan. None of theshares released were in respect of an award made to a director of the Company.Following this transaction, the trustee holds a total of 397,835 ordinaryshares in the Company. The executive directors of the Company are amongst thepotential beneficiaries under the Trust and are therefore regarded forCompanies Act purposes as being interested in the shares held in them pursuantto DR 3.1.4R(1)(6).Tatjana MayCompany SecretaryFor further information please contact:Investor Relations Clĩa Rosenfeld (Rest of the World) +44 1256 894 160 Brian Piper (North America) +1 484 595 8252 Notes to editorsSHIRE PLCShire's strategic goal is to become the leading specialty pharmaceuticalcompany that focuses on meeting the needs of the specialist physician. Shirefocuses its business on central nervous system (CNS), gastrointestinal (GI),general products (GP) and human genetic therapies (HGT) - all being areas inwhich Shire has a commercial presence. The structure is sufficiently flexibleto allow Shire to target new therapeutic areas to the extent opportunitiesarise through acquisitions. Shire believes that a carefully selected portfolioof products with a strategically aligned and relatively small-scale sales forcewill deliver strong results. Shire's focused strategy is to develop and marketproducts for specialty physicians. This approach aims to deliver increasedreturns and lower risks. Shire's in-licensing and merger and acquisitionefforts are focused on products in niche markets with strong intellectualproperty protection either in the US or Europe.For further information on Shire, please visit the Company's website: www.shire.com. Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release Registered in England 2883758 Registered Office as aboveENDSHIRE PLCRelated Shares:
Shire